查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1178084

脂質製劑的全球市場:脂質來源，各用途，各流通管道，各地區，產業規模，佔有率，趨勢，競爭，機會，預測(2017年～2027年)

Lipid Based Formulations Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Source of Lipids, By Application, By Distribution Channel, By Region
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球脂質製劑的市場規模在預測期間(2023年～2027年)中預計將以驚人的年複合成長率成長。

對尖端醫療的需求劇增和口服給藥藥的需求增加，慢性疾病·感染疾病·傳染病的增加，促進了市場的成長。

本報告提供全球脂質製劑市場相關調查分析，提供產品概要，市場展望，競爭情形等系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 全球脂質製劑市場上COVID-19影響

第4章 摘要整理

第5章 VOC (客戶的迴響)

  • 偏好:脂質來源
  • 影響脂質製劑需求的因素
  • 採用基於脂質的製劑的障礙
  • 品牌知名度

第6章 臨床試驗

  • 進行中的臨床試驗
  • 完成的臨床試驗
  • 中斷的臨床試驗
  • 臨床試驗分析

第7章 專利分析

  • 取得專利的(2017年～2021年)
  • 專利申請

第8章 市售的脂質製劑的清單

第9章 全球脂質製劑市場展望

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 脂質來源(天然化學合成)
    • 各用途(真菌性疾病，腫瘤學，基因治療，抗病毒疫苗，其他)
    • 各流通管道(零售藥局，醫院藥局，線上藥局)
    • 各企業(2021年)
    • 各地區
  • 產品市場地圖

第10章 北美的脂質製劑市場展望

第11章 歐洲的脂質製劑市場展望

第12章 亞太地區的脂質製劑市場展望

第13章 南美的脂質製劑市場展望

第14章 中東及非洲的脂質製劑市場展望

第15章 市場動態

  • 促進因素
  • 課題

第16章 市場趨勢與開發

第17章 競爭情形

  • Novartis AG
  • AbbVie, Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Alnylam Pharmaceuticals Inc.

第18章 策略性建議

簡介目錄
Product Code: 8209

Global lipid based formulations market is anticipated to grow with an impressive CAGR in the forecast period, 2023-2027, on account of growing pharmaceutical industry. Rapidly surging demands for the advanced medicine and growing demand for oral administrated medicine is driving the growth of the global lipid formulations market in the upcoming five years.

Lipid based formulations are bio-chemical compounds that are artificially synthesized to facilitate the drug administration, while ensuring safety of the drug along with bio-solubility of it for the digestion and faster action of the main drug component inside the formulation. Lipid based formulations aid the primary mechanism of action for the drug that leads to bioavailability. In simpler terms, highly water soluble drugs if gets dissolved in the starting of gut, may not reach the target site, or target organ and thus its efficiency decreases. To alter this effect, a lipid based formulation is utilized. Lipids form a hydrophobic bonds around the drug and avoid dissolution partially or completely until it reaches the target site. With digestion of the lipid bonds by the process of triglyceride digestion, the drug gets delivered in the later parts of gastrointestinal tract.

Pharmaceutical Advancements Drive Market Growth

Consistent research and development of the drugs such that they have higher bio-availability, higher effect on the target site, to improve facilitation of the drug to create its effect at the target site, is driving the growth of the global lipid based formulations market in the upcoming five years. A major concern among the drug delivery system is that, for the oral administration of the drug, it has tendency to get dissolved or digested before reaching the target site. In such cases, the drug if get dissolved would leave the gastrointestinal tract without being absorbed in the blood. To avoid this untimely dissolution, lipid based formulations are utilized to enhance the drug durability and absorption thus substantially increasing its affinity as a treatment for a particular diseases.

Growing Investments In Healthcare Industry Supports Market

Governments from major economies are actively investing in their respective healthcare sectors to enhance the services and products such that best possible patient care can be provided. Increasing instances of chronic, infectious, and communicable diseases, is further anticipated to drive the growth of the global lipid based formulations market in the upcoming five years. Consistent research and technological advancement for the pharmaceutical product development and advancement of the drug delivery systems, is also anticipated to substantiate the growth of the global lipid based formulations market in the future five years.

Market Segmentation

The global lipid based formulations market segmentation is based on source of lipids, application, distribution channel, regional distribution, and competitive landscape. Based on source of lipids, the market is differentiated between natural and chemically synthesized sources. Application based segments of the market is distinguished among fungal diseases, oncology, gene therapy, antiviral vaccines, and others. Based on distribution channel, the market is fragmented into retail pharmacies, hospital pharmacies, and online pharmacies. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc., are enlisted in a partial list of major market players of the global lipid based formulations market.

Report Scope:

In this report, global lipid based formulations market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Lipid Based Formulations Market, By Source of Lipids:

Natural

Chemically Synthesized

  • Lipid Based Formulations Market, By Application:

Fungal Diseases

Oncology

Gene Therapy

Antiviral Vaccines

Others

  • Lipid Based Formulations Market, By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

  • Lipid Based Formulations Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global lipid based formulations market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Lipid Based Formulations Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Preference, By Source of Lipids
  • 5.2. Factors Contributing to Demand for Lipid Based Formulations
  • 5.3. Barriers to Adoption of Lipid Based Formulations
  • 5.4. Brand Awareness

6. Clinical Trials

  • 6.1. Ongoing Clinical Trials
  • 6.2. Completed Clinical Trials
  • 6.3. Terminated Clinical Trials
  • 6.4. Clinical Trial Analysis

7. Patent Analysis

  • 7.1. Patent Granted (2017-2021)
  • 7.2. Patent Applications Filed

8. List of Commercially Available Lipid Based Formulations

9. Global Lipid Based Formulations Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source of Lipids (Natural v/s Chemically Synthesized)
    • 9.2.2. By Application (Fungal Diseases, Oncology, Gene Therapy, Antiviral Vaccines, Others)
    • 9.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 9.2.4. By Company (2021)
    • 9.2.5. By Region
  • 9.3. Product Market Map

10. North America Lipid Based Formulations Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source of Lipids
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. North America: Country Analysis
    • 10.3.1. United States Lipid Based Formulations Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source of Lipids
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Mexico Lipid Based Formulations Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source of Lipids
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Canada Lipid Based Formulations Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source of Lipids
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Distribution Channel

11. Europe Lipid Based Formulations Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Source of Lipids
    • 11.2.2. By Application
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. Europe: Country Analysis
    • 11.3.1. France Lipid Based Formulations Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Source of Lipids
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Germany Lipid Based Formulations Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Source of Lipids
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. United Kingdom Lipid Based Formulations Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Source of Lipids
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Distribution Channel
    • 11.3.4. Italy Lipid Based Formulations Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Source of Lipids
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By Distribution Channel
    • 11.3.5. Spain Lipid Based Formulations Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Source of Lipids
        • 11.3.5.2.2. By Application
        • 11.3.5.2.3. By Distribution Channel

12. Asia-Pacific Lipid Based Formulations Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Source of Lipids
    • 12.2.2. By Application
    • 12.2.3. By Distribution Channel
    • 12.2.4. By Country
  • 12.3. Asia-Pacific: Country Analysis
    • 12.3.1. China Lipid Based Formulations Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Source of Lipids
        • 12.3.1.2.2. By Application
        • 12.3.1.2.3. By Distribution Channel
    • 12.3.2. India Lipid Based Formulations Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Source of Lipids
        • 12.3.2.2.2. By Application
        • 12.3.2.2.3. By Distribution Channel
    • 12.3.3. South Korea Lipid Based Formulations Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Source of Lipids
        • 12.3.3.2.2. By Application
        • 12.3.3.2.3. By Distribution Channel
    • 12.3.4. Japan Lipid Based Formulations Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Source of Lipids
        • 12.3.4.2.2. By Application
        • 12.3.4.2.3. By Distribution Channel
    • 12.3.5. Australia Lipid Based Formulations Market Outlook
      • 12.3.5.1. Market Size & Forecast
        • 12.3.5.1.1. By Value
      • 12.3.5.2. Market Share & Forecast
        • 12.3.5.2.1. By Source of Lipids
        • 12.3.5.2.2. By Application
        • 12.3.5.2.3. By Distribution Channel

13. South America Lipid Based Formulations Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Source of Lipids
    • 13.2.2. By Application
    • 13.2.3. By Distribution Channel
    • 13.2.4. By Country
  • 13.3. South America: Country Analysis
    • 13.3.1. Brazil Lipid Based Formulations Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Source of Lipids
        • 13.3.1.2.2. By Application
        • 13.3.1.2.3. By Distribution Channel
    • 13.3.2. Argentina Lipid Based Formulations Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Source of Lipids
        • 13.3.2.2.2. By Application
        • 13.3.2.2.3. By Distribution Channel
    • 13.3.3. Colombia Lipid Based Formulations Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Source of Lipids
        • 13.3.3.2.2. By Application
        • 13.3.3.2.3. By Distribution Channel

14. Middle East and Africa Lipid Based Formulations Market Outlook

  • 14.1. Market Size & Forecast
    • 14.1.1. By Value
  • 14.2. Market Share & Forecast
    • 14.2.1. By Source of Lipids
    • 14.2.2. By Application
    • 14.2.3. By Distribution Channel
    • 14.2.4. By Country
  • 14.3. MEA: Country Analysis
    • 14.3.1. South Africa Lipid Based Formulations Market Outlook
      • 14.3.1.1. Market Size & Forecast
        • 14.3.1.1.1. By Value
      • 14.3.1.2. Market Share & Forecast
        • 14.3.1.2.1. By Source of Lipids
        • 14.3.1.2.2. By Application
        • 14.3.1.2.3. By Distribution Channel
    • 14.3.2. Saudi Arabia Lipid Based Formulations Market Outlook
      • 14.3.2.1. Market Size & Forecast
        • 14.3.2.1.1. By Value
      • 14.3.2.2. Market Share & Forecast
        • 14.3.2.2.1. By Source of Lipids
        • 14.3.2.2.2. By Application
        • 14.3.2.2.3. By Distribution Channel
    • 14.3.3. UAE Lipid Based Formulations Market Outlook
      • 14.3.3.1. Market Size & Forecast
        • 14.3.3.1.1. By Value
      • 14.3.3.2. Market Share & Forecast
        • 14.3.3.2.1. By Source of Lipids
        • 14.3.3.2.2. By Application
        • 14.3.3.2.3. By Distribution Channel

15. Market Dynamics

  • 15.1. Drivers
  • 15.2. Challenges

16. Market Trends & Developments

17. Competitive Landscape

  • 17.1. Novartis AG
  • 17.2. AbbVie, Inc.
  • 17.3. F. Hoffmann-La Roche AG
  • 17.4. Johnson & Johnson
  • 17.5. Alnylam Pharmaceuticals Inc.

18. Strategic Recommendations